GlobeNewswire Inc | Jul 29, 2020 07:00AM EDT

July 29, 2020

CRESSKILL, N.J. and JERUSALEM, Israel, July 29, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced that it will report its second quarter 2020 financial results and operational highlights before the open of the U.S. financial markets onWednesday, August 12, 2020. The Company will host a conference call and webcast at 8:30 AM Eastern Timeto discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date: Wednesday, August 12, 2020Time: 8:30 AM Eastern TimeUnited States: 877-407-3982Israel: 1 809 406 247International: 201-493-6780Conference ID: 13706952Webcast: http://public.viavid.com/index.php?id=140751

The conference call will be broadcast live and will be available for replay for 30 days on the Companys website, https://investors.brainsway.com/financial-calendar. Please access the Companys website at least 10 minutes ahead of the conference call to register.

About BrainsWayBrainsWay is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Companys proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which BrainsWay received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 for MDD and in 2018 for OCD. BrainsWay is currently conducting clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders.

Forward Looking StatementsAny forward-looking statements are subject to risks and uncertainties such as those described in BrainsWay's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:BrainsWay Judy Huber SVP and Chief Financial OfficerJudy.huber@brainsway.com

Investors:Bob YedidLifeSci Advisors 646-597-6989Bob@LifeSciAdvisors.com